Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

TOKYO and CAMBRIDGE, Mass., Sept. 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of the Supplemental Biologics License…

Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure

Kawasaki, Japan and San Jose, USA, September 3, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, 1Finity Inc., a Fujitsu company and leading provider of global network solutions, and Arrcus Inc., the hyperscale networking software company and a leader in core, edge, and multi-cloud routing and switching infrastructure, today…

sureWin Entertainment Sponsors Daesung's 2025 Singapore Concert, Reinforcing Its Role in Asian Pop Culture and Exclusive Fan Experiences

Singapore – sureWin Entertainment, Asia's top-rated online entertainment platform, is proud to announce its official sponsorship of the highly anticipated Daesung "D's Wave" Asia Tour stop in Singapore. Scheduled for 2 August 2025 at 8 PM, the concert will be held at Arena @ EXPO, a recently upgraded 6,700-capacity venue…

sureWin Entertainment Sponsors Black Eyed Peas' '30 Years Strong' Concert in Singapore, Marking a Double Hit in Global Pop Partnerships

Singapore - sureWin Entertainment, Asia's top-rated online entertainment platform, proudly announces its official sponsorship of the Black Eyed Peas' "30 Years Strong" concert, set to take place on Monday, 25 August 2025 at 8 PM at the Singapore Indoor Stadium. This event follows closely on the heels of sureWin's partnership…

Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT

Massachusetts, USA, September 2, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation ("MC”) is pleased to announce its participation in a third-party allotment of shares by Commonwealth Fusion Systems LLC (Headquarter: Massachusetts, USA, Representative: Bob Mumgaard, “CFS”), a fusion energy start-up originating from MIT *1. This investment was made in…

Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework “SAFe(R)”

TOKYO, September 2, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE:6501, "Hitachi") has been certified as a Gold Partner*1 of Scaled Agile, Inc. ("SAI"), the provider of SAFe®, the world's most trusted system for business agility.SAFe is a management framework that supports organizational transformation and business agility, helping…

FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, MA, August 30, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License…

TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) – Applications for Research Projects Open on September 1

TOKYO, Sept 1, 2025 - (JCN Newswire via SeaPRwire.com) - TANAKA Memorial Foundation (Representative Director: Hideya Okamoto) has announced that it will be accept applications for research themes for FY2025 Precious Metals Research Grants from September 1 to November 28, 2025. This grant program aims to contribute to the development of…

Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

TOKYO, August 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received orphan drug designation for anticancer agent the EZH2*1 inhibitor tazemetostat hydrobromide (generic name, product name “Tazverik® Tablets 200 mg”, “tazemetostat”) for unresectable INI1*2-negative epithelioid sarcoma…

Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage

Completion of strategic acquisition affirms Hitachi Energy’s position as a market and technology leader in advancing energy storage innovation - a cornerstone of secure energy transitionsPower electronics with advanced digital capabilities are critical to ensure reliability and stability of the electric gridZurich, Switzerland, August 28, 2025 - (JCN Newswire via…

Alibaba (9988.HK), Huitongda Network (9878.HK), and Wanchen Group (300972.SZ) are all jumping on this “new trend” with accelerating development

EQS Newswire / 01/09/2025 / 15:25 UTC+8 During Alibaba's (9988.HK) earnings call on August 29th, CEO Eddie Wu explicitly identified two strategic opportunities for Alibaba: a technology platform centered on "AI + Cloud", and a large-scale consumer platform integrating shopping and lifestyle services. Wu emphasized, "Alibaba's approach to instant retail isn't…

me88 news Launches as a New Sports Journalism Platform with Comprehensive Multi-Sport Coverage and Expert Analysis

New York, NY – September 01, 2025 – (SeaPRwire) – me88news, a dedicated sports journalism platform, announced its official launch today, designed to provide comprehensive coverage and expert analysis across four key competitive disciplines: Formula 1, E-sports, Badminton, and Martial Arts. Addressing the Information Gap in Sports Media The launch of me88 news responds…

Huitongda Network (9878.HK) reported satisfactory 2025 interim results, with three key profit metrics reaching record highs; AI-related revenue brings accelerating growth

EQS Newswire / 01/09/2025 / 12:14 UTC+8 On the evening of August 28, Huitongda Network (9878.HK) released its 2025 interim results. During the reporting period, Huitongda Network achieved an operating profit of RMB356 million, representing a year-on-year (“YoY”) increase of 15.9%; profit attributable to equity shareholders of the company reached RMB139 million,…

Huitongda Network (9878.HK) reported satisfactory 2025 interim results, with three key profit metrics reaching record highs; AI-related revenue brings accelerating growth

EQS Newswire / 01/09/2025 / 12:14 UTC+8 On the evening of August 28, Huitongda Network (9878.HK) released its 2025 interim results. During the reporting period, Huitongda Network achieved an operating profit of RMB356 million, representing a year-on-year (“YoY”) increase of 15.9%; profit attributable to equity shareholders of the company reached RMB139 million,…